Certain Options of Aurinia Pharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 12-JUN-2017. These Options will be under lockup for 90 days starting from 14-MAR-2017 to 12-JUN-2017. Details: The executive officers and directors have agreed not to sell or transfer any common shares or securities convertible into or exchangeable or exercisable for common shares, for 90 days after the date of the prospectus supplement without first obtaining the written consent of Leerink Partners LLC on behalf of the underwriters.